Optovue Stock

optovue.comHealthcareFounded: 2003Funding to Date: $44.77MM

Optovue is a medical device company focused on developing the next generation of ophthalmic optical coherence tomography (OCT) instruments.

Register for Details

For more details on financing and valuation for Optovue, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Optovue.

Register Today

Team

Management Team

David Voris
President & Chief Financial Officer
Dragos Stanescu
Director, Mechanical Engineering
Jay Wei
Chief Executive Officer, Founder and President
Larry Alexander
Senior Director, Clinical Education

Other companies like Optovue in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM

News

FREMONT, Calif.—Optovue, Inc., a global leader in the development and commercialization of optical coherence tomography (OCT) and OCT angiography technology for the eyecare market, announced it has executed an agreement to receive $30 million in private equity funding from Deltronics (Netherlands) B.V., a subsidiary of Taiwan-based Delta Electronics, Inc., a global leader in power and thermal management solutions.